Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers

References

• Moss A. J., Schwartz P. J., Crampton R. S., Tzivoni D., Locati E. H., MacCluer J., et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991; 84: 1136–44
   PubMed Web of Science ®Google Scholar
• Vincent G. M., Timothy K. M., Leppert M., Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for long QT syndrome. N Engl J Med 1992; 327: 846–52
   PubMed Web of Science ®Google Scholar
• Schwartz P. J., Moss A. J., Vincent G. M., et al. Diagnostic criteria for the long QT syndrome: an update. Circulation 1993; 88: 782–4
   PubMed Web of Science ®Google Scholar
• Romano C., Gemme G., Pongiglione R. Aritmie cardiache rare dell'eta pediatrica. Clin Pediatr 1963; 45: 656–83
   Google Scholar
• Ward O. C. A new familial cardiac syndrome in children. J Irish Med Assoc 1964; 54: 103–6
   PubMedGoogle Scholar
• Jervell A., Lange‐Nielsen F. Congenital deaf‐mutism, functional heart disease with prolongation of the QT interval, and sudden death. Am Heart J 1957; 54: 59–68
   PubMed Web of Science ®Google Scholar
• Nemec J., Hejlik J. B., Shen W. K., Ackerman M. J. Catecholamine‐induced T‐wave lability in congenital long QT syndrome: a novel phenomenon associated with syncope and cardiac arrest. Mayo Clin Proc 2003; 78: 40–50
   PubMed Web of Science ®Google Scholar
• Moss A. J., Robinson J. L. The long QT syndrome. Circulation 2002; 105: 784–6
   Web of Science ®Google Scholar
• Fraser G. R., Froggatt P., James T. N. Congenital deafness associated with electrocardiographic abnormalities, fainting attacks and sudden death. Q J Med 1964; 33: 361–85
   PubMedGoogle Scholar
• Tranebjærg L., Bathen J., Tyson J., Bitner‐Glindzicz M. Jervell and Lange‐Nielsen syndrome: a Norwegian perspective. Am J Med Genet 1999; 89: 137–46
   PubMed Web of Science ®Google Scholar
• Priori S. G., Schwartz P. J., Napolitano C., Bloise R., Ronchetti E., Grillo M., et al. Risk stratification in the long‐QT syndrome. N Engl J Med 2003; 348: 1866–74
   PubMed Web of Science ®Google Scholar
• Moss A. J. Prolonged QT interval syndromes. J Am Med Assoc 1986; 256: 2985–7
   Web of Science ®Google Scholar
• Ackerman M. J. The long QT syndrome: ion channel diseases of the heart. Mayo Clin Proc 1998; 73: 250–69
   PubMed Web of Science ®Google Scholar
• Vincent G. M. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death. Annu Rev Med 1998; 49: 263–74
   PubMed Web of Science ®Google Scholar
• Priori S. G., Aliot E., Blomstrom‐Lundquist C., Bossaert L., Breithardt G., Brugada P., et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 2001; 22: 1374–450
   PubMed Web of Science ®Google Scholar
• Schwartz P. J. The congenital long QT syndromes from genotype to phenotype: clinical implications. J Intern Med 2006; 259: 39–47
   PubMed Web of Science ®Google Scholar
• Schwartz P. J., Spazzolini C., Crotti L., Bathen J., Amlie J. P., Timothy K., et al. The Jervell and Lange‐Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006; 113: 783–90
   PubMed Web of Science ®Google Scholar
• Schwartz P. J., Priori S. G., Spazzolini C., Moss A. J., Vincent G. M., Napolitano C., et al. Genotype‐phenotype correlation in the long‐QT syndrome: gene‐specific triggers for life‐threatening arrhythmias. Circulation 2001; 103: 89–95
   PubMed Web of Science ®Google Scholar
• Zareba W., Moss A. J., Locati E. H., Lehmann M. H., Peterson D. R., Hall W. J., et al. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype. J Am Coll Cardiol 2003; 42: 103–9
   PubMed Web of Science ®Google Scholar
• Priori S. G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachcardia. Circulation 2001; 103: 196–200
   PubMed Web of Science ®Google Scholar
• Ramensky V., Bork P., Sunayev S. Human non‐synonymous SNPs: server and survey. Nucleic Acids Res 2002; 30: 3894–900
   PubMed Web of Science ®Google Scholar
• Napolitano C., Priori S. G., Schwartz P. J., Bloise R., Ronchetti E., Nastoli J., et al. Genetic testing in the long QT syndrome. J Am Med Assoc 2005; 294: 2975–80
   PubMed Web of Science ®Google Scholar
• Vincent G. M., Timothy K., Fox J., Zhang L. The inherited long‐QT syndrome: from ion channel to bedside. Cardiol Rev 1999; 7: 44–55
   PubMedGoogle Scholar
• Tester D. J., Ackerman M. J. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007; 49: 240–6
   PubMed Web of Science ®Google Scholar
• Puranik R., Chow C. K., Duflou J. A., Kilborn M. J., McGuire M. A. Sudden death in the young. Heart Rhythm 2005; 2: 1277–82
   PubMed Web of Science ®Google Scholar
• Splawski I., Shen J., Timothy K. W., Lehmann M. H., Priori S., Robinson J. L., et al. Spectrum of mutations in long‐QT syndrome genes. Circulation 2000; 102: 1178–85
   PubMed Web of Science ®Google Scholar
• Fodstad H., Swan H., Laitinen P., Piippo K., Paavonen K., Viitasalo M., et al. Four potassium channel mutations account for 73% of the genetic spectrum underlying long‐QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland. Ann Med 2004; 36(Suppl 1)53–63
   PubMed Web of Science ®Google Scholar
• van Langen I. M., Hofman N., Tan H. L., Wilde A. A. M. Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med 2004; 36(Suppl 1)116–23
   PubMed Web of Science ®Google Scholar
• Imboden M., Swan H., Denjoy I., Van Langen I. M., Latinen‐Forsblom P. J., Napolitano C., et al. Female predominance and transmission distortion in the long‐QT syndrome. N Engl J Med 2006; 355: 2744–51
   PubMed Web of Science ®Google Scholar
• Tester D. J., Kopplin L. J., Will M. L., Ackerman M. J. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2005; 2: 1099–105
   PubMed Web of Science ®Google Scholar
• Tester D. J., Spoon D. B., Valdivia H. H., Makielski J. C., Ackerman M. J. Targeted mutational analysis of the RyR2‐encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc 2004; 79: 1380–4
   PubMed Web of Science ®Google Scholar